CNZLX | FICCX | CNZLX / FICCX | |
Total Expense Ratio | 2.86 | 1.04 | 275% |
Annual Report Gross Expense Ratio | 2.86 | 1.04 | 275% |
Fund Existence | 33 years | 18 years | - |
Gain YTD | -8.566 | -6.390 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 200 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.2M | 910M | 1% |
Annual Yield % from dividends | 1.13 | 1.54 | 73% |
Returns for 1 year | -11.07 | -8.64 | 128% |
Returns for 3 years | -33.86 | -6.92 | 490% |
Returns for 5 years | -0.50 | 57.85 | -1% |
Returns for 10 years | -9.66 | 26.39 | -37% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXI | 31.68 | 2.09 | +7.06% |
iShares China Large-Cap ETF | |||
ONEY | 102.26 | 6.74 | +7.05% |
SPDR® Russell 1000® Yield Focus ETF | |||
BUFG | 23.36 | 1.46 | +6.67% |
FT Vest Buffered Allocation Gr ETF | |||
BBP | 53.00 | 2.46 | +4.86% |
Virtus LifeSci Biotech Products ETF | |||
RSBT | 15.65 | 0.03 | +0.18% |
Return Stacked Bonds & Managed Futs ETF |